Literature DB >> 7927702

Epithelial glucosphingolipid expression as a determinant of bacterial adherence and cytokine production.

M Svensson1, R Lindstedt, N S Radin, C Svanborg.   

Abstract

D-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) is a structural analog of ceramide that inhibits glucosylation of this molecule and thus of glucosphingolipid (GSL) expression by living cells. In this study, we used PDMP to slow the synthesis of the globoseries of GSLs (globo-GSLs) (derived from the precursor Gal alpha 1-4Gal beta 1-4Glc-ceramide) by cultured human kidney and large intestinal epithelial cells. The aim was to deplete the cells of receptors for P-fimbriated Escherichia coli and to examine the effects on the bacterially induced cytokine response. The mammalian cells (A498, HT-29, and Caco2) were cultured in the presence of PDMP in order to deplete them of GSLs. The cells were then subjected to GSL analysis or used to test bacterial adherence and cytokine production. The globo-GSLs were identified by thin-layer chromatography. Bacterial adherence was quantitated by microscopy, and interleukin-6 secretion was quantitated by the B9 bioassay. The interaction of bacteria with the globo-GSLs was studied by using E. coli strains and recombinant clones expressing P fimbriae. E. coli strains expressing type 1 fimbriae binding to mannose-containing glycoproteins were used as controls. PDMP treatment was found to reduce the content of the globo-GSLs in mammalian cells and the adherence of P-fimbriated E. coli to these cells. In contrast, PDMP treatment had no effect on the adherence of type 1-fimbriated E. coli or their activation of cytokine production by A498 cells. P-fimbriated E. coli elicited an interleukin-6 response in the A498 cells; this response was reduced after treatment with PDMP. The results emphasize the role of GSLs as receptors for P-fimbriated E. coli and for the cytokine response elicited by attaching bacteria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927702      PMCID: PMC303123          DOI: 10.1128/iai.62.10.4404-4410.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Adhesion of Escherichia coli to human uroepithelial cells in vitro.

Authors:  C S Eden; B Eriksson; L A Hanson
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

2.  A growth-factor dependent B-cell hybridoma.

Authors:  P M Lansdorp; L A Aarden; J Calafat; W P Zeiljemaker
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

Review 3.  Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances.

Authors:  N S Radin; J A Shayman; J Inokuchi
Journal:  Adv Lipid Res       Date:  1993

4.  Evidence for erythrocyte membrane glycoproteins being carriers of blood-group P1 determinants.

Authors:  C G Haselberger; H Schenkel-Brunner
Journal:  FEBS Lett       Date:  1982-11-22       Impact factor: 4.124

5.  Globoseries glycosphingolipids of human meconium.

Authors:  G Larson
Journal:  Arch Biochem Biophys       Date:  1986-05-01       Impact factor: 4.013

6.  Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1----4Gal-containing glycosphingolipids.

Authors:  K Bock; M E Breimer; A Brignole; G C Hansson; K A Karlsson; G Larson; H Leffler; B E Samuelsson; N Strömberg; C S Edén
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

7.  Globoside-specific adhesins of uropathogenic Escherichia coli are encoded by similar trans-complementable gene clusters.

Authors:  B Lund; F P Lindberg; M Båga; S Normark
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

8.  Cloning of genes determining the production of mannose-resistant fimbriae in a uropathogenic strain of Escherichia coli belonging to serogroup O6.

Authors:  S Clegg
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

9.  Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate.

Authors:  R A Hull; R E Gill; P Hsu; B H Minshew; S Falkow
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

10.  GalNAc beta 1----3 terminated glycosphingolipids of human erythrocytes.

Authors:  J Angström; H Karlsson; K A Karlsson; G Larson; K Nilson
Journal:  Arch Biochem Biophys       Date:  1986-12       Impact factor: 4.013

View more
  7 in total

Review 1.  Bacterial perturbation of cytokine networks.

Authors:  M Wilson; R Seymour; B Henderson
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Studies of the action of ceramide-like substances (D- and L-PDMP) on sphingolipid glycosyltransferases and purified lactosylceramide synthase.

Authors:  S Chatterjee; T Cleveland; W Y Shi; J Inokuchi; N S Radin
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

3.  Individual profiles of free ceramide species and the constituent ceramide species of sphingomyelin and neutral glycosphingolipid and their alteration according to the sequential changes of environmental oxygen content in human colorectal cancer Caco-2 cells.

Authors:  Kouji Tanaka; Keiko Tamiya-Koizumi; Masaki Yamada; Takashi Murate; Reiji Kannagi; Mamoru Kyogashima
Journal:  Glycoconj J       Date:  2013-12-06       Impact factor: 2.916

4.  Escherichia coli induces transuroepithelial neutrophil migration by an intercellular adhesion molecule-1-dependent mechanism.

Authors:  W W Agace; M Patarroyo; M Svensson; E Carlemalm; C Svanborg
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 5.  Treatment of Gaucher disease with an enzyme inhibitor.

Authors:  N S Radin
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

6.  Shiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Julia S Schmitz; Daniel Steil; Hans-Ulrich Humpf; Helge Karch; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2017-10-25       Impact factor: 4.546

7.  Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli.

Authors:  M Hedlund; M Svensson; A Nilsson; R D Duan; C Svanborg
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.